A first in man, phase I dose-escalation study of...

Cell Cycle 2011 / 03 Vol. 10; Iss. 6

A first in man, phase I dose-escalation study of PHA-793887, an inhibitor of multiple cyclin-dependent kinases (CDK2, 1 and 4) reveals unexpected hepatotoxicity in patients with solid tumors 



Massard, Christophe, Soria, Jean-Charles, Anthoney, D. Alan, Proctor, A., Scaburri, Angela, Pacciarini, Maria Adele, Laffranchi, Bernard, Pellizzoni, Cinzia, Kroemer, Guido, Armand, Jean-Pierre, Balhe
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
10
Journal:
Cell Cycle
DOI:
10.4161/cc.10.6.15075
Date:
March, 2011
File:
PDF, 1.46 MB
2011
Conversion to is in progress
Conversion to is failed